Showing 1 - 5 results of 5 for search 'Federica Perrone', query time: 0.01s Refine Results
  1. 1
    Gain of ALK gene copy number may predict lack of benefit from anti-EGFR treatment in patients with advanced colorectal cancer and RAS-RAF-PI3KCA wild-type status.

    Gain of ALK gene copy number may predict lack of benefit from anti-EGFR treatment in patients with advanced colorectal cancer and RAS-RAF-PI3KCA wild-type status. by Filippo Pietrantonio, Claudia Maggi, Maria Di Bartolomeo, Maria Grazia Facciorusso, Federica Perrone, Adele Testi, Roberto Iacovelli, Rosalba Miceli, Ilaria Bossi, Giorgia Leone, Massimo Milione, Giuseppe Pelosi, Filippo de Braud

    Published 2014-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Detecting gene copy number alterations by Oncomine Comprehensive genomic profiling in a comparative study on FFPE tumor samples

    Detecting gene copy number alterations by Oncomine Comprehensive genomic profiling in a comparative study on FFPE tumor samples by Fabio Bozzi, Elena Conca, Marco Silvestri, Gianpaolo Dagrada, Alice Ardore, Donata Penso, Daniele Lorenzini, Chiara Costanza Volpi, Desirè Viola Trupia, Adele Busico, Iolanda Capone, Federica Perrone, Elena Tamborini, Andrea Vingiani, Luca Agnelli, Giancarlo Pruneri

    Published 2025-02-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Impact of comprehensive genomic profiling and molecular tumour board on costs and access to tailored therapies: real-world observational study

    Impact of comprehensive genomic profiling and molecular tumour board on costs and access to tailored therapies: real-world observational study by Adele Busico, Elena Conca, Filippo de Braud, Claudia Proto, Claudio Vernieri, Claudio Jommi, Siranoush Manoukian, Luca Agnelli, Monica Niger, Federica Perrone, Daniele Lorenzini, Giancarlo Pruneri, Elena Tamborini, Andrea Vingiani, Valentina De Micheli, Victoria Lucia Rabsiun Aramburu, Anna Baggi, Matteo Duca, Alberta Piccolo, Iolanda Capone, Giovanni Gancitano, Matteo Ferrario, Jean Marie Franzini

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Molecular Characterization and Clinical Relevance of MGMT‐Silenced Pancreatic Cancer

    Molecular Characterization and Clinical Relevance of MGMT‐Silenced Pancreatic Cancer by Federico Nichetti, Marco Silvestri, Luca Agnelli, Andrea Franza, Chiara Pircher, Simone Rota, Paolo Ambrosini, Giuseppe Fotia, Jennifer Hüllein, Giovanni Randon, Panna Lajer, Federica Perrone, Elena Tamborini, Giuseppe Leoncini, Jorgelina Coppa, Michele Droz Dit Busset, Sara Pusceddu, Massimo Milione, Federica Morano, Filippo Pietrantonio, Giancarlo Pruneri, Vincenzo Mazzaferro, Daniel B. Lipka, Bruno Christian Köhler, Daniel Hübschmann, Stefan Fröhling, Filippo deBraud, Monica Niger

    Published 2024-12-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Genomic instability and CCNE1 amplification as emerging biomarkers for stratifying high-grade serous ovarian cancer

    Genomic instability and CCNE1 amplification as emerging biomarkers for stratifying high-grade serous ovarian cancer by Elena Conca, Daniele Lorenzini, Daniele Lorenzini, Emanuela Minna, Luca Agnelli, Matteo Duca, Marco Gentili, Beatrice Bodini, Maggie Polignano, Mara Mantiero, Silvia Damian, Andrea Devecchi, Gianpaolo Dagrada, Rita Carminati, Alice Ardore, Francesca Barbetta, Nathalia Brito Da Chuna, Andrea Guerrizio, Adele Busico, Iolanda Capone, Alberta Piccolo, Elena Tamborini, Federica Perrone, Massimo Milione, Biagio Paolini, Andrea Vingiani, Andrea Vingiani, Francesco Raspagliesi, Francesco Raspagliesi, Filippo De Braud, Filippo De Braud, Giancarlo Pruneri, Giancarlo Pruneri

    Published 2025-08-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: